The Effect of Cangrelor and Access Site on Ischemic and Bleeding Events – Insights from CHAMPION PHOENIX J. Antonio Gutierrez, MD, MHS, Robert A. Harrington, - ppt download
Subanalyses of the CHAMPION PHOENIX trial. | Download Scientific Diagram
Hallway Buzz: CHAMPION PHOENIX Trial with Deepak Bhatt, MD | MedPageToday
CHAMPION PHOENIX trial
Effect of Platelet Inhibition with Cangrelor during PCI on Ischemic Events | NEJM
Table 1 from Efficacy and Safety of Cangrelor in Women Versus Men During Percutaneous Coronary Intervention | Semantic Scholar
Figure1 | THE EFFICACY, SAFETY, AND NET CLINICAL BENEFIT OF CANGRELOR IN WOMEN UNDERGOING ELECTIVE OR URGENT PCI: INSIGHTS FROM THE CHAMPION-PHOENIX TRIAL | JACC: Journal of the American College of Cardiology
Impact of Cerebrovascular Events Older Than One Year on Ischemic and Bleeding Outcomes With Cangrelor in Percutaneous Coronary Intervention | Circulation: Cardiovascular Interventions
Table 5 from Intravenous antiplatelet therapies (glycoprotein IIb/IIIa receptor inhibitors and cangrelor) in percutaneous coronary intervention: from pharmacology to indications for clinical use | Semantic Scholar
CHAMPION PHOENIX IPST: Implications of Intraprocedural Stent Thrombosis During PCI from a Prospective, Randomized Trial of a Potent Intravenous ADP Antagonist vs. a Standard Ora... | tctmd.com
BCRI - Clinical Trials
Incidence and Impact of Stent Thrombosis During Percutaneous Coronary Intervention: Comparison of Cangrelor and Clopidogrel from the CHAMPION PHOENIX Trial | tctmd.com
PDF) CHAMPION PHOENIX Trial
Cangrelor in Older Patients Undergoing Percutaneous Coronary Intervention
Table 3 from Making Sense of Statistics in Clinical Trial Reports: Part 1 of a 4-Part Series on Statistics for Clinical Trials. | Semantic Scholar
Cangrelor Superior to Clopidogrel in CHAMPION PHOENIX Trial | DAIC
Effect of Platelet Inhibition with Cangrelor during PCI on Ischemic Events | NEJM
PPT - CHAMPION PHOENIX PowerPoint Presentation, free download - ID:2257235
CHAMPION-PHOENIX (IV Cangrelor vs Oral Clopidogrel for the Management of Periprocedural PCI Complications)
Figure S1: CHAMPION PHOENIX Study Design | Download Scientific Diagram
Investigator-Reported Bleeding Versus Post Hoc Adjudication of Bleeding: Lessons From the CHAMPION PHOENIX Trial | Journal of the American College of Cardiology
Pro Position: The Data - Phoenix and Meta-Analysis of the Champion Clinical Trial Program! | tctmd.com
Impact of Intraprocedural Stent Thrombosis During Percutaneous Coronary Intervention
Off Hours” Versus “On Hours” Presentation in ST-Segment Elevation Myocardial Infarction: Findings from CHAMPION PHOENIX | tctmd.com
CHAMPION-PHOENIX (IV Cangrelor vs Oral Clopidogrel for the Management of Periprocedural PCI Complications)
Effect of Platelet Inhibition with Cangrelor during PCI on Ischemic Events | NEJM
Effect of Platelet Inhibition with Cangrelor during PCI on Ischemic Events | NEJM
